These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7517180)

  • 1. Doppler ultrasound of the uteroplacental circulation in the prediction of pregnancy outcome in women with raised maternal serum alpha-fetoprotein.
    Robson M; Hamid R; McParland P; Pearce JM
    Br J Obstet Gynaecol; 1994 Jun; 101(6):477-80. PubMed ID: 7517180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose aspirin in women with raised maternal serum alpha-fetoprotein and abnormal Doppler waveform patterns from the uteroplacental circulation.
    Hamid R; Robson M; Pearce JM
    Br J Obstet Gynaecol; 1994 Jun; 101(6):481-4. PubMed ID: 7517181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels.
    Konchak PS; Bernstein IM; Capeless EL
    Am J Obstet Gynecol; 1995 Oct; 173(4):1115-9. PubMed ID: 7485303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women.
    Coleman MA; McCowan LM; North RA
    Ultrasound Obstet Gynecol; 2000 Jan; 15(1):7-12. PubMed ID: 10776006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine artery Doppler in the investigation of pregnancies with raised maternal serum alpha-fetoprotein.
    Aristidou A; Van den Hof MC; Campbell S; Nicolaides K
    Br J Obstet Gynaecol; 1990 May; 97(5):431-5. PubMed ID: 1695525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of pre-eclampsia, low birthweight for gestation and prematurity by uterine artery blood flow velocity waveforms analysis in low risk nulliparous women.
    Irion O; Massé J; Forest JC; Moutquin JM
    Br J Obstet Gynaecol; 1998 Apr; 105(4):422-9. PubMed ID: 9609270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Uteroplacental and fetal arterial Ultrasound Doppler Flow Velocity measurements in unselected pregnancies as a screening test at 32 to 34 gestational weeks].
    Hüneke B; Ude C
    Z Geburtshilfe Neonatol; 2002 Apr; 206(2):57-64. PubMed ID: 12015636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twin pregnancies in the second trimester in women in an alpha-fetoprotein screening program: sonographic evaluation and outcome.
    Pretorius DH; Budorick NE; Scioscia AL; Krabbe JK; Ko S; Myhre CM
    AJR Am J Roentgenol; 1993 Nov; 161(5):1007-13. PubMed ID: 7506005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doppler assessment of the uterine and uteroplacental circulation in the second trimester in pregnancies at high risk for pre-eclampsia and/or intrauterine growth retardation: comparison and correlation between different Doppler parameters.
    Zimmermann P; Eiriö V; Koskinen J; Kujansuu E; Ranta T
    Ultrasound Obstet Gynecol; 1997 May; 9(5):330-8. PubMed ID: 9201877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between second trimester maternal serum alpha-fetoprotein and umbilical artery Doppler velocimetry and their association with preterm delivery.
    Weiner CP; Grant SS; Williamson RA
    Am J Perinatol; 1991 Jul; 8(4):263-8. PubMed ID: 1720619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical value of combining maternal serum screening and uterine artery Doppler in prediction of adverse pregnancy outcome.
    Elsandabesee D; Srinivas M; Kodakkattil S
    J Obstet Gynaecol; 2006 Feb; 26(2):115-7. PubMed ID: 16483965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of uterine artery Doppler in the prediction of uteroplacental complications in multiparous women.
    Harrington K; Fayyad A; Thakur V; Aquilina J
    Ultrasound Obstet Gynecol; 2004 Jan; 23(1):50-5. PubMed ID: 14971000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perinatal outcome in pregnancies with a positive serum screening for Down's syndrome due to elevated levels of free beta-human chorionic gonadotropin.
    Palacio M; Jauniaux E; Kingdom J; Dell E; Sheldrake A; Rodeck CH
    Ultrasound Obstet Gynecol; 1999 Jan; 13(1):58-62. PubMed ID: 10201088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-trimester prediction of severe placental complications in women with combined elevations in alpha-fetoprotein and human chorionic gonadotrophin.
    Alkazaleh F; Chaddha V; Viero S; Malik A; Anastasiades C; Sroka H; Chitayat D; Toi A; Windrim RC; Kingdom JC
    Am J Obstet Gynecol; 2006 Mar; 194(3):821-7. PubMed ID: 16522419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doppler flow velocity waveform analysis in high risk pregnancies: a randomized controlled trial.
    Newnham JP; O'Dea MR; Reid KP; Diepeveen DA
    Br J Obstet Gynaecol; 1991 Oct; 98(10):956-63. PubMed ID: 1751442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doppler investigation of uteroplacental blood flow resistance in the second trimester: a screening study for pre-eclampsia and intrauterine growth retardation.
    Bewley S; Cooper D; Campbell S
    Br J Obstet Gynaecol; 1991 Sep; 98(9):871-9. PubMed ID: 1911605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements.
    Simpson JL; Palomaki GE; Mercer B; Haddow JE; Andersen R; Sibai B; Elias S
    Am J Obstet Gynecol; 1995 Dec; 173(6):1742-8. PubMed ID: 8610755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
    Toal M; Chaddha V; Windrim R; Kingdom J
    J Obstet Gynaecol Can; 2008 Mar; 30(3):198-206. PubMed ID: 18364097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of third trimester uterine artery flow velocity indices in relationship to perinatal complications.
    Ghosh G; Breborowicz A; Brazert M; Maczkiewicz M; Kobelski M; Dubiel M; Gudmundsson S
    J Matern Fetal Neonatal Med; 2006 Sep; 19(9):551-5. PubMed ID: 16966123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.